| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/01/2006 | EP1621197A2 Composition comprising a steroid and an anticholinergic agent |
| 02/01/2006 | EP1621195A2 The use of pyridinic NK-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 02/01/2006 | EP1621188A1 Ultraviolet-shielding type patch |
| 02/01/2006 | EP1620429A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 02/01/2006 | EP1620406A2 1,2-diarylimidazoles useful as inhibitors of cox |
| 02/01/2006 | EP1620182A1 Methods for treating sinus headache |
| 02/01/2006 | EP1620108A2 Pyrazole-amine compounds useful as kinase inhibitors |
| 02/01/2006 | EP1620106A1 Pharmaceutical composition comprising a cathepsin s inhibitor and an opioid |
| 02/01/2006 | EP1620102A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 02/01/2006 | EP1620084A1 Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract |
| 02/01/2006 | EP1500654B1 Benzoxazinone derivatives, the preparation and use thereof as medicaments |
| 02/01/2006 | EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 02/01/2006 | EP1463707A4 A group of novel anti-cancer compounds with specific structure |
| 02/01/2006 | EP1430144A4 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 02/01/2006 | EP1425281B1 Tricyclic CRF receptor antagonists |
| 02/01/2006 | EP1343492B1 Treatment of mucositis |
| 02/01/2006 | EP1235812B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 02/01/2006 | EP1212376B1 Synthetic vegetal melanins, process for their production and compositions containing them |
| 02/01/2006 | EP1194409B1 Pyrazolidinol compounds |
| 02/01/2006 | EP1169336B1 Ent-steroids as selectively active estrogens |
| 02/01/2006 | EP1146894B1 Uses of thank protein, a tnf homologue, to inhibit growth of tumour cells |
| 02/01/2006 | EP1133315B1 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases |
| 02/01/2006 | EP1104289B1 New oral formulation for 5-ht4 agonists or antagonists |
| 02/01/2006 | EP1080078B1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 02/01/2006 | EP1064402B1 Antisense modulation of lfa-3 |
| 02/01/2006 | CN1729192A Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 02/01/2006 | CN1729160A Drugs for chronic pain |
| 02/01/2006 | CN1728999A Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/01/2006 | CN1728993A Pharmaceutical composition comprising lumiracoxib |
| 02/01/2006 | CN1727354A Compound in category of trioside methyl salicylate, oside ester saccharide |
| 02/01/2006 | CN1726998A Combination of Chinese traditional medicine for treating rheumatoid arthritis and artjritis pauperum |
| 02/01/2006 | CN1726994A Soft capsule for promoting blood circulation to stop pain, and preparing technique |
| 02/01/2006 | CN1726979A Sustained release preparation of root of indian stringbush |
| 02/01/2006 | CN1726974A Snake plum wine for expelling pathogenic wind |
| 02/01/2006 | CN1726934A Medication combination of Xuefu Zhuyu in application for preparing hypolipidemic |
| 02/01/2006 | CN1726926A Injection medication of emu oil for antiinflammation and ease pain, and preparation method |
| 02/01/2006 | CN1726918A Method for preparing Meloxicam freeze-dry powder |
| 02/01/2006 | CN1726914A Slow release tablet of rotundine and production process |
| 02/01/2006 | CN1239491C Method for extracting total phenyl phthalein of ligusitcum wallichii |
| 02/01/2006 | CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 02/01/2006 | CN1239478C 3,4-dibidro-1H-anphthalene derivatives used as high selectivity inhibitor of cyclooxygenase-2 |
| 02/01/2006 | CN1239201C Bone peptide for injection and its preparation method |
| 02/01/2006 | CN1239178C Method for preparing qingkailing granules |
| 02/01/2006 | CN1239176C Lamina ointment for quickly treating burn and preparation method thereof |
| 02/01/2006 | CN1239174C Chinese medicine composition for treating lumbago and scelalgia and hyperosteogeny and its preparing method |
| 02/01/2006 | CN1239172C Medicinal preparation for wind dispelling and pain arresting |
| 02/01/2006 | CN1239162C Pain killing medicine composition |
| 02/01/2006 | CN1239160C Hormone replacement therapy |
| 01/31/2006 | USRE38963 for treating a migraine, disorders associated with inflammation, menstrual disorders, respiratory disorders, gastrointestinal afflications, skin disorders |
| 01/31/2006 | US6992192 preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase used for prophylaxis of erectile dysfunction and cardiovascular disorders |
| 01/31/2006 | US6992189 Such as 4-((Z)-(4-bromophenyl)(ethoxyimno)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine; for the treatment of AIDS and related HIV infections |
| 01/31/2006 | US6992095 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 01/31/2006 | US6992094 selenium nicotinic acid tetrahyronaphthaline compounds; treating skin disorders |
| 01/31/2006 | US6992086 Antagonists of MCP-1 function and methods of use thereof |
| 01/31/2006 | US6992084 Compounds and methods for modulating CXCR3 function |
| 01/31/2006 | US6992074 2-Ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 01/31/2006 | US6992068 Brazilian licorice extract and periandrins, which are constituents thereof, have an anti inflammatory effect and an immunosuppressive effect |
| 01/31/2006 | US6991810 a glycoprotein used as an industrial component such as an antifoulant, or an anti-adhesive, or as a pharmaceutical component such as an anti-inflammatory agent. |
| 01/31/2006 | US6991785 Administering by tissue absorption |
| 01/31/2006 | CA2327498C Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 01/31/2006 | CA2314154C Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 01/31/2006 | CA2208839C Quinuclidine derivatives and medicinal composition thereof |
| 01/26/2006 | WO2006009464A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 01/26/2006 | WO2006009325A1 Metalloprotease inhibitor |
| 01/26/2006 | WO2006009309A1 Galectin 9-binding protein factor |
| 01/26/2006 | WO2006009209A1 Preventive or therapeutic agent for chronic inflammatory lung disease |
| 01/26/2006 | WO2006009114A1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 01/26/2006 | WO2006009092A1 Method of effectively using medicine and method concerning prevention of side effect |
| 01/26/2006 | WO2005110002A3 Anti-inflammatory and anticeptic suppository exhibiting a regeneration effect |
| 01/26/2006 | US20060020138 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/26/2006 | US20060020046 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies |
| 01/26/2006 | US20060020008 Compounds, compositions and methods |
| 01/26/2006 | US20060019999 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 01/26/2006 | US20060019988 Compounds, compositions, and methods |
| 01/26/2006 | US20060019977 Spiroheterocyclic derivative compounds and drugs comprising the compound as the active ingredient |
| 01/26/2006 | US20060019958 Immunity-related protein kinase inhibitors |
| 01/26/2006 | US20060019945 Granzyme b inhibitors |
| 01/26/2006 | US20060019930 Treatment and prevention of tissue damage |
| 01/26/2006 | US20060019925 Peritoneal dialysis method |
| 01/26/2006 | US20060019294 Tyrosine kinase substrate (Tks) proteins |
| 01/26/2006 | US20060018903 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease |
| 01/26/2006 | US20060018892 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis |
| 01/26/2006 | CA2572047A1 Octahydropyrrolo[2,3,c]pyridine derivatives and pharmaceutical use thereof |
| 01/26/2006 | CA2571881A1 Heterocyclic derivatives for modulation of calcium channels |
| 01/25/2006 | EP1619205A1 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
| 01/25/2006 | EP1619203A1 Galectin 9-inducing factor |
| 01/25/2006 | EP1619194A2 Triazaspiro[5.5]undecane derivatives and pharmaceutical composition comprising the same as active ingredient |
| 01/25/2006 | EP1619193A1 Spiropiperidine compound and medicinal use thereof |
| 01/25/2006 | EP1619192A2 Aryl fused azapolycyclic compounds |
| 01/25/2006 | EP1619180A1 CaSR ANTAGONIST |
| 01/25/2006 | EP1618892A1 Instrument for inducing cytokine and method of inducing cytokine |
| 01/25/2006 | EP1618884A1 Instrument for inducing cytokine and method of inducing cytokine |
| 01/25/2006 | EP1618880A1 Use of compounds derived from 2,3-dehydronaringenin for the treatment of inflammatory processes and pharmaceutical composition containing said derivatives |
| 01/25/2006 | EP1618879A1 Injectable formulations of taxanes for cad treatment |
| 01/25/2006 | EP1618196A2 Dna-based aptamers for human cathepsin g |
| 01/25/2006 | EP1617830A2 Esterified fatty acid composition |
| 01/25/2006 | EP1617803A2 Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
| 01/25/2006 | EP1372627B1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 01/25/2006 | EP1235825B1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 01/25/2006 | EP1115408B1 Oxihumic acid and its use in the treatment of various conditions |